Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival

Amino Acids

Volumn 44, Issue 1, 2013, Pages 73-80

  Kim, Se Jin ^a   Kim, Kyung Hee ^a   Ahn, Eu Ree ^a   Yoo, Byong Chul ^a   Kim, Soo Youl ^a  

^a National Cancer Center   (South Korea)

Author keywords

Apoptosis; Cathepsin D; Transglutaminase 2

Indexed keywords

CASPASE 3; CATHEPSIN D; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL LEVEL; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEFICIENCY; FIBROBLAST; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CATHEPSIN D; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CYCLOHEXIMIDE; ENZYMES, IMMOBILIZED; GENE KNOCKOUT TECHNIQUES; GTP-BINDING PROTEINS; GUINEA PIGS; HUMANS; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; TANDEM MASS SPECTROMETRY; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 84871955140     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1089-6     Document Type: Article

References (35)

1. Boehm JE, Singh U, Combs C, Antonyak MA, Cerione RA (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem 277:20127-20130
2. Facchiano F, D'Arcangelo D, Riccomi A, Lentini A, Beninati S, Capogrossi MC (2001) Transglutaminase activity is involved in polyamine-induced programmed cell death. Exp Cell Res 271:118-129
3. Fesus L, Thomazy V, Falus A (1987) Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224:104-108
4. Folk JE (1980) Transglutaminases. Annu Rev Biochem 49:517-531
5. Folk JE, Chung SI (1985) Transglutaminases. Methods Enzymol 113:358-375
6. Folk JE, Cole PW (1965) Structural requirements of specific substrates for guinea pig liver transglutaminase. J Biol Chem 240:2951-2960
7. Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10:561-574
8. Heinrich M et al (2004) Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 11:550-563
9. Iismaa SE, Mearns BM, Lorand L, Graham RM (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89:991-1023
10. Jang GY et al (2010) Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene 29:356-367
11. Kagedal K, Johansson U, Ollinger K (2001) The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15:1592-1594
12. Kim DS, Han BG, Park KS, Lee BI, Kim SY, Bae CD (2010) I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway. Biochem Biophys Res Commun 399:300-306
13. Kim DS, Park KS, Kim SY (2009) Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors. Front Biosci 14:2514-2521
14. Kim DS, Park SS, Nam BH, Kim IH, Kim SY (2006) Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res 66:10936-10943
15. Kim SY (2006) Transglutaminase 2 in inflammation. Front Biosci 11:3026-3035
16. Kim SY (2011) Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease. Advances in enzymology and related areas of molecular biology, vol 78, Wiley, Durham, pp 161-195
17. Kim SY, Kim IG, Chung SI, Steinert PM (1994) The structure of the transglutaminase 1 enzyme. Deletion cloning reveals domains that regulate its specific activity and substrate specificity. J Biol Chem 269:27979-27986
18. Lee J et al (2004) Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem 279:53725-53735
19. Mastroberardino PG et al (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9:873-880
20. Miyashita T et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
21. Park KS et al (2009) Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett 274:201-207
22. Park KS, Kim DS, Ko C, Lee SJ, Oh SH, Kim SY (2011) TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2. Front Biosci (Elite Ed) 3:341-354
23. Park SS, Kim JM, Kim DS, Kim IH, Kim SY (2006) Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster. J Biol Chem 281:34965-34972
24. Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, Melino G (1991) The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 54:246-254
25. Roberg K, Kagedal K, Ollinger K (2002) Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 161:89-96
26. Rossin F, D'Eletto M, Macdonald D, Farrace MG, Piacentini M (2011) TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy. Amino Acids (in press)
27. Ruan Q, Quintanilla RA, Johnson GV (2007) Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin. J Neurochem 102:25-36
28. Salvesen GS (2001) A lysosomal protease enters the death scene. J Clin Invest 107:21-22
29. Sarkar NK, Clarke DD, Waelsch H (1957) An enzymically catalyzed incorporation of amines into proteins. Biochim Biophys Acta 25:451-452
30. Shibata M et al (1998) Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 251:199-203
31. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA 100:7812-7817
32. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P, Venuta S (2004) NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia 18:11-17
33. Wong DW, Batt CA, Kinsella JE (1991) Expression of the transglutaminase gene in Escherichia coli. Int J Biochem 23:947-953
34. Wu GS, Saftig P, Peters C, El-Deiry WS (1998) Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16:2177-2183
35. Yamaguchi H, Wang HG (2006) Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells. Mol Cell Biol 26:569-579